HEMATOLOGICAL MALIGNANCIES
Clinical trials for HEMATOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on tough T-Cell cancers in new trial
Disease control Not yet recruitingThis study tests a new treatment for people with aggressive T-cell blood cancers, like certain leukemias and lymphomas. It uses specially engineered natural killer (NK) cells from donated cord blood, designed to target and destroy cancer cells. Participants will receive these cel…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:02 UTC
-
New stem cell transplant could help more blood cancer patients
Disease control Not yet recruitingThis study tests a new way to do stem cell transplants for adults with high-risk blood cancers who don't have a fully matched donor. Doctors will use a special process to remove certain immune cells from the donor's stem cells before transplant, aiming to reduce severe side effec…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: NA • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated May 26, 2026 08:59 UTC
-
MRNA cancer therapy takes aim at resistant blood cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called WGb-0302 for people with blood cancers like multiple myeloma that have come back or stopped responding to other treatments. The drug uses mRNA technology (similar to some COVID-19 vaccines) to help the body target cancer cells. About…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: Sichuan University • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
In-body CAR-T therapy could make cancer treatment faster and cheaper
Disease control Not yet recruitingThis early-phase study tests a new type of immunotherapy for people with B-cell blood cancers like lymphoma and leukemia. Instead of removing immune cells, modifying them in a lab, and putting them back, this treatment delivers a messenger RNA (mRNA) payload directly into the bod…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Blood cancer Patients' hidden therapies revealed in new french study
Knowledge-focused Not yet recruitingThis study looks at how people with blood cancers in France use complementary and alternative medicines like acupuncture or herbal remedies. Researchers will survey 85 patients and interview some to understand why they use these therapies and how it affects their well-being. The …
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated May 26, 2026 08:57 UTC